Ariyaratne Dinuka, Senadheera Bhagya, Kuruppu Heshan, Pramanayagam Jayadas Tibutius Thanesh, Gomes Laksiri, Ranasinghe Diyanath, Bary Farha, Wijewickrama Ananda, Agulilar Sully Márquez, Bennett Shannon, Jeewandara Chandima, Malavige Gathsaurie Neelika
Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka.
National Institute of Infectious Diseases, Angoda, Sri Lanka.
J Infect Dis. 2025 Apr 15;231(4):1041-1048. doi: 10.1093/infdis/jiae474.
We observed a discrepancy between dengue NS1 antigen test and molecular diagnostics, with the emergence of dengue virus (DENV) serotype 3 in Sri Lanka, and sought to understand the cause for the rise in cases and high failure rates of molecular diagnostics.
Whole-genome sequencing was carried out in 22 DENV-3 samples. Phylogenetic and molecular clock analyses were done for genotype assignment and to understand the rate of evolution. Mutation analysis was done to understand the reasons for polymerase chain reaction (PCR) nondetection.
We identified 2 DENV-3 genotypes (I and III) cocirculating. DENV-3 genotype III strains shared a common ancestor with a sequence from India collected in 2022, while DENV-3 genotype I, was found to share a common ancestor with DENV-3 sequences from China. DENV-3 genotype III was detected by the modified Centers for Disease Control and Prevention DENV-3 primers, whereas genotype I evaded detection due to key mutations at forward and reverse primer binding sites. We identified point mutations C744T and A756G in the forward primer binding sites and G795A in the reverse primer binding sites, which were not identified in DENV-3 genotype III. Furthermore, our Sri Lankan DENV-3 strains demonstrated a high root to tip ratio compared to the previous DENV-3 sequences, indicating a high mutation rate during the time of sampling (2017 to 2023).
The cocirculation of multiple genotypes associated with an increase in cases highlights the importance of continuous surveillance of DENVs to identify mutations resulting in nondetection by diagnostics and differences in virulence.
在斯里兰卡出现登革热病毒3型(DENV-3)时,我们观察到登革热NS1抗原检测与分子诊断之间存在差异,并试图了解病例增加以及分子诊断失败率高的原因。
对22份DENV-3样本进行全基因组测序。进行系统发育和分子钟分析以进行基因型分型并了解进化速率。进行突变分析以了解聚合酶链反应(PCR)检测不到的原因。
我们鉴定出两种DENV-3基因型(I和III)同时流行。DENV-3基因型III毒株与2022年从印度收集的一个序列有共同祖先,而DENV-3基因型I被发现与来自中国的DENV-3序列有共同祖先。改良的美国疾病控制与预防中心DENV-3引物检测到了DENV-3基因型III,而基因型I由于正向和反向引物结合位点的关键突变而未被检测到。我们在正向引物结合位点鉴定出点突变C744T和A756G,在反向引物结合位点鉴定出G795A,这些突变在DENV-3基因型III中未被发现。此外,与之前的DENV-3序列相比,我们的斯里兰卡DENV-3毒株显示出较高的根到末端比率,表明在采样期间(2017年至2023年)突变率较高。
多种基因型同时流行且病例增加凸显了持续监测登革热病毒以识别导致诊断检测不到的突变以及毒力差异的重要性。